Clinical Trials Logo

Clinical Trial Summary

objective of LUNG-I3 study is to assess the quantitative and functional differences in cells between blood and bronchoalveolar lavage (BAL) fluid after an infection, with a special focus on alveolar macrophages and neutrophils


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06073834
Study type Observational
Source BioMérieux
Contact Jean-François LLITJOS
Phone +33761568397
Email jeanfrancois.llitjos@biomerieux.com
Status Not yet recruiting
Phase
Start date November 2023
Completion date September 2025

See also
  Status Clinical Trial Phase
Completed NCT05575050 - Impact of Teeth Brushing in Ventilated COVID-19 Patients. N/A
Not yet recruiting NCT06035796 - Performance Study of Targeted Sequencing Technology for VAP
Not yet recruiting NCT06410664 - Efficiency and Safety of the Prolonged Use of Heat and Moisture Exchangers in ICU N/A
Not yet recruiting NCT06045429 - Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisation Phase 4
Not yet recruiting NCT04955821 - Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS
Completed NCT04038814 - The Effectiveness of the Modified Bundle in the Prevention of VAP.
Completed NCT05230472 - Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia Phase 4
Not yet recruiting NCT05738928 - Microbiological Profile of VAP Patients in Respiratory ICU
Completed NCT05176353 - Ventilator-associated Pneumonia (VAP) Diagnostic Stewardship Trial N/A
Recruiting NCT05952648 - HAP/VAP Diagnosis in Critically Ill Septic Patients Using a Multiplex PCR Array N/A